Principal Biostatistician FSP, Late Phase at IQVIA

Durham, North Carolina, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceutical, Clinical ResearchIndustries

Requirements

PhD in Statistics, Biostatistics, or related field or MS in Statistics, Biostatistics, or related field
PhD: 5+ years industry experience or MS: 7+ years industry experience
At least 3 years in Phase 2/3 clinical trial experience
Demonstrated ability to work proactively and independently
Ability to effectively communicate ideas and manage programmers constructively
Proficiency in R or SAS for efficacy and safety analyses and data validation
Understanding of ICH GCP, ICH E9

Responsibilities

Collaborate with multi-disciplinary project teams to establish project objectives and timelines
Write the statistical sections of clinical trial protocols, consulting with internal and external experts
Author statistical analysis plans
Monitor internal and CRO project activities, including timelines, deliverables, and resource availability
Collaborate with Data Management, Clinical Development, and Clinical Operations, providing statistical expertise
Contribute to clinical study reports and other regulatory documents (e.g., NDA, DSURs, Briefing Documents, ISS, ISE)
Provide guidance and supervision to programmers in authoring analysis dataset specifications and programming/validation of tables, listings, and figures
Interpret study results and review reports of study results for accuracy
Support exploratory analyses
Participate in pre-IND or NDA activities
Participate in other activities and meetings to support Biostatistics and the Development Team as needed

Skills

SAS

Biostatistics

Clinical Trials

Statistical Analysis Plans

ICH GCP

ICH E9

Data Validation

Statistical Programming

Regulatory Documents

IQVIA

Advanced analytics and clinical research services

About IQVIA

IQVIA provides advanced analytics, technology solutions, and clinical research services specifically for the life sciences industry. Their services utilize extensive data resources and technology to create connections within healthcare, allowing clients to gain insights that help speed up the development and marketing of new medical treatments. This process is facilitated by their IQVIA Connected Intelligence™ system, which offers quick and flexible insights. IQVIA stands out from competitors by focusing on patient privacy, employing various technologies to protect individual data. The company's goal is to enhance healthcare outcomes by supporting biotech, pharmaceutical, and medical device companies, as well as researchers and government agencies, in understanding diseases and advancing medical science.

Durham, North CarolinaHeadquarters

1998Year Founded

$3,526MTotal Funding

POST_IPO_EQUITYCompany Stage

Cybersecurity, Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Rapid advancement of cancer vaccines may disrupt traditional clinical research models.

Proliferation of disparate technological solutions causes technology overload in clinical trials.

Generative AI technologies face challenges in adoption due to data privacy concerns.

Differentiation

IQVIA leverages advanced analytics and big data for life sciences solutions.

The company offers privacy-enhancing technologies to protect individual patient data.

IQVIA's AI Assistant provides rapid, actionable insights for healthcare and life sciences.

Upsides

Increased adoption of decentralized clinical trials enhances patient-centric study designs.

AI-driven drug discovery accelerates identification of potential drug candidates.

Expansion of telemedicine facilitates remote patient monitoring and data collection.

Land your dream remote job 3x faster with AI

Try Jobo Free